Oncology Perspective

• Medscape Cardiologist Wealth & Debt Report 2022 What percentage of cardiologists have a net worth exceeding $5 million? How aggressively are these cardiologists saving or investing? This report explores how cardiologists are building wealth.
  Medscape Features Slideshows, August 05, 2022
• Medscape Endocrinologist Wealth & Debt Report 2022 What percentage of endocrinologists have a net worth exceeding $5 million? How aggressively are these endocrinologists saving or investing? This report explores how endocrinologists are building wealth.
  Medscape Features Slideshows, August 05, 2022
• Medscape Family-physician Wealth & Debt Report 2022 What percentage of family physicians have a net worth exceeding $5 million? How aggressively are these family physicians saving or investing? This report explores how family physicians are building wealth.
  Medscape Features Slideshows, August 05, 2022
• Medscape Internist Wealth & Debt Report 2022 What percentage of internists have a net worth exceeding $5 million? How aggressively are these internists saving or investing? This report explores how internists are building wealth.
  Medscape Features Slideshows, August 05, 2022
• Medscape Oncologist Wealth & Debt Report 2022 What percentage of oncologists have a net worth exceeding $5 million? How aggressively are these oncologists saving or investing? This report explores how oncologists are building wealth.
  Medscape Features Slideshows, August 05, 2022
• Medscape Psychiatrist Wealth & Debt Report 2022 What percentage of psychiatrists have a net worth exceeding $5 million? How aggressively are these psychiatrists saving or investing? This report explores how psychiatrists are building wealth.
  Medscape Features Slideshows, August 05, 2022
• Medscape Neurologist Wealth & Debt Report 2022 What percentage of neurologists have a net worth exceeding $5 million? How aggressively are these neurologists saving or investing? This report explores how neurologists are building wealth.
  Medscape Features Slideshows, August 05, 2022
• Treatment of Early Non-Small Cell Lung Cancer: Getting the Diagnosis Right   Jeffrey Thiboutot, MD, MHS, recalls a case where a relatively new diagnostic technique clarified the true nature of a patient's condition.
  Medscape, August 05, 2022
• Why In-Flight Emergency Kits Need an Update   Robert D. Glatter, MD; Andrea Merrill, MD; Amy Ho, MD, MPH; and Lianne Mandelbaum discuss the challenges of using in-flight emergency kits.
  Medscape Emergency Medicine, August 05, 2022
• Infographic: Salary and Bonus Trends for Medical Residents Salaries are stagnating for residents, who reveal what they need to cover their living expenses and medical school loans.
  Medscape, August 05, 2022
• Why We Order Lab Tests Redux Is ordering a test that comes back negative a sham treatment or a good placebo?
  Medscape Internal Medicine, August 03, 2022
• Infographic: Physician Suicide One in 10 physicians have had thoughts about or attempted suicide, according to our survey. To whom could you confide such thoughts?
  Medscape, August 03, 2022
• Treatment of Early Breast Cancer: A Foreseeable Future for Adjuvant Therapy   Clinton Yam, MD, expounds on the need for adjuvant therapies for early breast cancer in the context of recalling a patient experience from residency.
  Medscape, August 01, 2022
• Management of Early-Stage Breast Cancer: Breaking Down the Barriers to Screening and Prevention   Tarah J. Ballinger, MD, discusses the problems surrounding the utilization of breast cancer screening and prevention methods.
  Medscape, August 01, 2022
• Management of Early-Stage Breast Cancer: Reducing the Risk for Recurrence   Tarah J. Ballinger, MD, proposes a future informed by precise therapeutic monitoring for patients with early-stage breast cancer.
  Medscape, August 01, 2022
• Early NSCLC: Achieving a Fitting Response to a Heterogeneous Disease   Sandip Patel, MD, stresses the importance of collaboration in early non–small cell lung cancer care.
  Medscape, August 01, 2022
• Live Meetings: Is the Juice Still Worth the Squeeze? Are live meetings worth the cost and hassle of travel, let alone the risk for COVID?
  Medscape Oncology, August 01, 2022
• Treatment of Metastatic Breast Cancer: A Multiplication of Options   Avan J. Armaghani, MD, compares the current metastatic breast cancer therapeutic scene with that of the past.
  Medscape, August 01, 2022
• Medscape Residents Salary & Debt Report 2022 In this year's report, residents weigh in on whether their compensation is enough, their student loan debt, and professional relationships.
  Medscape Features Slideshows, July 29, 2022
• Personalized Decision-Making in the Treatment of Early-Stage Breast Cancer   Tarah J. Ballinger, MD, discusses what she has learned from her day-to-day patient interactions and the nuanced decisions that patients with early-stage breast cancer make as they share in the decision-making process.
  Medscape, July 29, 2022